Key points are not available for this paper at this time.
The population with end-stage renal disease (ESRD) in the United States is composed of more than 200,000 patients who undergo dialysis and 70,000 patients with functioning kidney transplants.1 With the prevalence of ESRD growing at a rate between 7 and 9 percent per year, it is projected that there will be more than 350,000 such patients by the year 2010.2 Although the overall incidence of ESRD is 242 cases per million population per year, blacks have a disproportionately high incidence (758 per million population per year), as compared with whites (180 per million population per year).1 Diabetes is the leading . . .
Pastan et al. (Thu,) studied this question.